| Literature DB >> 31025612 |
Rebekah Mannix1, Roger Zemek2, Keith Owen Yeates3, Kristy Arbogast4, Shireen Atabaki5, Mohammed Badawy6, Miriam H Beauchamp7, Darcy Beer8, Steven Bin9, Brett Burstein10, William Craig11, Dan Corwin4, Quynh Doan12, Michael Ellis13, Stephen B Freedman14, Isabelle Gagnon15, Jocelyn Gravel16, John Leddy17, Angela Lumba-Brown18, Christina Master19, Andrew R Mayer20, Grace Park21, Michelle Penque22, Tara Rhine23, Kelly Russell24, Kathryn Schneider25, Michael Bell26, Stephen Wisniewski27.
Abstract
Given the lack of evidence regarding effective pharmacological and non-pharmacological interventions for pediatric mild traumatic brain injury (mTBI) and the resultant lack of treatment recommendations reflected in consensus guidelines, variation in the management of pediatric mTBI is to be expected. We therefore surveyed practitioners across 15 centers in the United States and Canada who care for children with pediatric mTBI to evaluate common-practice variation in the management of pediatric mTBI. The survey, developed by a panel of pediatric mTBI experts, consisted of a 10-item survey instrument regarding providers' perception of common pediatric mTBI symptoms and mTBI interventions. Surveys were distributed electronically to a convenience sample of local experts at each center. Frequencies and percentages (with confidence intervals [CI]) were determined for survey responses. One hundred and seven respondents (71% response rate) included specialists in pediatric Emergency Medicine, Sports Medicine, Neurology, Neurosurgery, Neuropsychology, Neuropsychiatry, Physical and Occupational Therapy, Physiatry/Rehabilitation, and General Pediatrics. Respondents rated headache as the most prevalently reported symptom after pediatric mTBI, followed by cognitive problems, dizziness, and irritability. Of the 65 (61%; [95% CI: 51,70]) respondents able to prescribe medications, non-steroidal anti-inflammatory medications (55%; [95% CI: 42,68]) and acetaminophen (59%; [95% CI: 46,71]) were most commonly recommended. One in five respondents reported prescribing amitriptyline for headache management after pediatric mTBI, whereas topiramate (8%; [95% CI: 3,17]) was less commonly reported. For cognitive problems, methylphenidate (11%; [95% CI: 4,21]) was used more commonly than amantadine (2%; [95% CI: 0,8]). The most common non-pharmacological interventions were rest ("always" or "often" recommended by 83% [95% CI: 63,92] of the 107 respondents), exercise (59%; [95%CI: 49,69]), vestibular therapy (42% [95%CI: 33,53]) and cervical spine exercises (29% [95%CI: 21,39]). Self-reported utilization for common pediatric mTBI interventions varied widely across our Canadian and United States consortium. Future effectiveness studies for pediatric mTBI are urgently needed to advance the evidence-based care.Entities:
Keywords: concussion; intervention; mild traumatic brain injury
Year: 2019 PMID: 31025612 DOI: 10.1089/neu.2018.6290
Source DB: PubMed Journal: J Neurotrauma ISSN: 0897-7151 Impact factor: 5.269